It seems that everyone is pairing up these days. From Abbott reaching a deal to buy St. Jude Medical for $25 billion, Sanofi making an offer to Medivation for $9.3 billion and AbbVie signing a deal with Stemcnetrx for $5.8 billion.

As a recent New York Times article explains, many in the industry are having the same idea: Pair up with your competitors to become a leading provider and gain power to negotiate business with hospitals and insurers.

Read more by following the link below: